The bill mandates a legislative management study during the 2025-26 interim focused on establishing reporting requirements for entities in North Dakota that participate in the federal drug discount program under 42 U.S.C. 256b. The study aims to explore how the data collected can be utilized to inform public policy that benefits patients in the state. It will consider which entities should report data, the specific data elements required, methods for reporting and sharing the data, confidentiality issues, and enforcement mechanisms, including potential civil penalties for non-compliance.

Additionally, the study will involve consultations with various stakeholders, including professional associations representing hospitals, pharmacies, and health centers, as well as the insurance department and the department of health and human services. The legislative management is tasked with reporting its findings and recommendations, along with any necessary legislation, to the seventieth legislative assembly.

Statutes affected:
INTRODUCED: 54-52.1-04.18
Adopted by the Senate Human Services Committee: 54-52.1-04.18
FIRST ENGROSSMENT: 54-52.1-04.18